<DOC>
	<DOCNO>NCT01046084</DOCNO>
	<brief_summary>The object study compare relative bioavailability lansoprazole 30 mg delayed-release capsule ( manufacture TEVA Pharmaceutical Industries , Ltd. distribute TEVA Pharmaceuticals USA ) PREVACIDÂ® capsule ( TAP Pharmaceuticals , Inc. ) healthy , adult , subject non-fasting condition .</brief_summary>
	<brief_title>Lansoprazole 30 mg DR Capsule Replicate Food Study</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA Bioequivalence Statistical Methods</detailed_description>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>18 year age old Body Mass Index 30 less Males nonpregnant female Normal clinical laboratory test result Subjects significant history chronic alcohol consumption ( past 2 year ) , drug addiction , serious gastrointestinal , renal , hepatic , cardiovascular disease , tuberculosis , epilepsy , asthma ( past 5 year ) , diabetes , psychosis glaucoma eligible study . Subjects whose clinical laboratory test value great 20 % outside normal range may retested . If clinical value outside range retesting , subject eligible participate study unless clinical investigator deem result significant . Subjects history allergic response class drug test exclude study . Subjects find urine concentration test drug allow participate . Subjects donate blood and/or plasma least 30 day prior first dose study . Subjects take investigational drug within 30 day prior first dose study allow participate . Female subject pregnant , breastfeeding , likely become pregnant study allow participate . Female subject child bear potential must either abstain sexual intercourse use reliable barrier method ( e.g . condom , IUD ) contraception course study ( first dose last blood collection ) allow participate . Female subject use hormonal oral contraceptive within 180 day dose allowed participate . Female subject positive inconclusive pregnancy test result withdrawn study . Subjects tolerate venipuncture allow participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>